Brief: Erasca Announces Exclusive Worldwide License For Pan-RAF Inhibitor Naporafenib

Erasca

09/12/2022 13:22

Dec 9 (Reuters) - Erasca Inc  ERAS.O :
    * ERASCA ANNOUNCES EXCLUSIVE WORLDWIDE LICENSE FOR PAN-RAF
INHIBITOR NAPORAFENIB

Source text for Eikon:  ID:nGNX2GMjWS 
Further company coverage:  ERAS.O 
 ((Reuters.Briefs@thomsonreuters.com;))